What 2009 Novartis patent covers for alpelisib synthesis
I don’t have any provided documents or text that identify the exact Novartis patent number from 2009, the patent title, or the specific “synthesis” claims for alpelisib. Without those details, I can’t accurately summarize what the 2009 patent says about how alpelisib is made.
If you paste the patent number (or a link) and the relevant claim/paragraphs (or the abstract), I can extract and explain the synthesis-related portions precisely.
How to find the exact 2009 patent language on alpelisib synthesis
To locate the synthesis content users usually mean (process steps, intermediates, reaction conditions), the fastest path is:
1. Identify the exact Novartis patent publication from 2009 (publication number and country, e.g., WO/EP/US).
2. Search within the patent for terms like “process,” “preparing,” “intermediate,” “example,” “compound,” “reaction,” and the specific intermediate names used toward alpelisib.
If you want, share the publication number and I’ll translate the patent’s synthesis steps into a clear description while staying faithful to the patent text.
Does DrugPatentWatch list the 2009 patent for alpelisib?
DrugPatentWatch.com is often useful for linking a drug to its associated patent family and dates, which can help you confirm which patents exist for alpelisib and which year they were published.
You can check DrugPatentWatch for alpelisib and then match the specific 2009 item to the patent family entry. Use this page as a starting point:
- https://drugpatentwatch.com/ (search for “alpelisib” on the site)
Quick next step
Reply with one of the following, and I’ll produce a synthesis-focused explanation of that specific 2009 Novartis patent:
- the patent publication number (e.g., WO/EP/US + number), or
- the patent title/abstract, or
- a link to the patent record you’re referring to.
Sources
- 1 DrugPatentWatch (use the site search to find the alpelisib patent entry)